Assuming FinalWire is privy to Intel's plans (and we don't know that for sure), the new BMG-G31 entry suggests that we'll ...

Boston-based Verve is a rare example of a gene editing company targeting a disease that affects a large population, offering ...

Lilly confirmed it would buy a Boston-based clinical-stage company developing genetic medicines for cardiovascular disease.

Eli Lilly will acquire Verve Therapeutics for up to $1.3 billion, the companies said on Tuesday. Verve is developing therapies targeting genes that regulate cholesterol in the liver.

US Big Pharma firm Eli Lilly & Co. agreed to buy gene-editing biotech company Verve Therapeutics Inc. for $1.3 billion as the ...

In this video, I will review some of the stock purchases made by members of the U.S. Congress. Politicians such as Nancy Pelosi and Marjorie Taylor Greene, among others, have acquired significant ...

Eli Lilly will acquire gene-editing startup Verve Therapeutics for up to US$1.3 billion to boost its pipeline beyond its blockbuster weight-loss and diabetes drugs.

Central Elementary School has released its honor roll for the fourth nine weeks and second semester of the 2024-2025 academic ...

The pending deal was rumored overnight after a report from the Financial Times, spurring analysts to speculate that if true, ...